BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16551818)

  • 1. Rhesus positivity and low high-density lipoprotein cholesterol: a new link?
    Kanbay M; Yildirir A; Ulus T; Bilgi M; Kucuk A; Muderrisoglu H
    Asian Cardiovasc Thorac Ann; 2006 Apr; 14(2):119-22. PubMed ID: 16551818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
    Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
    Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for coronary artery disease in patients with elevated high-density lipoprotein cholesterol.
    DeFaria Yeh D; Freeman MW; Meigs JB; Grant RW
    Am J Cardiol; 2007 Jan; 99(1):1-4. PubMed ID: 17196452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Magnitude and characteristics of residual lipid risk in patients with a history of coronary revascularization: the ICP-bypass study].
    González-Juanatey JR; Cordero A; Vitale GC; González-Timón B; Mazón P; Bertomeu V
    Rev Esp Cardiol; 2011 Oct; 64(10):862-8. PubMed ID: 21835533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The characteristics of high density lipoprotein cholesterol and the relationship between high density lipoprotein cholesterol and the severity of coronary artery lesions in young men with acute myocardial infarction].
    Li Z; Tao Y; Huang J; Wang Q; Zhang DH; Wu XY
    Zhonghua Yi Xue Za Zhi; 2013 May; 93(19):1458-62. PubMed ID: 24029567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low high-density lipoprotein cholesterol and other coronary heart disease risk factors in patients with total cholesterol levels greater than 5.17 mmol/L (200 mg/dL) in family practice. A report from CEN.
    J Am Board Fam Pract; 1991; 4(5):285-97. PubMed ID: 1746296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABO blood group in relation to plasma lipids and proprotein convertase subtilisin/kexin type 9.
    Li S; Xu RX; Guo YL; Zhang Y; Zhu CG; Sun J; Li JJ
    Nutr Metab Cardiovasc Dis; 2015 Apr; 25(4):411-7. PubMed ID: 25466598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines.
    Sachdeva A; Cannon CP; Deedwania PC; Labresh KA; Smith SC; Dai D; Hernandez A; Fonarow GC
    Am Heart J; 2009 Jan; 157(1):111-117.e2. PubMed ID: 19081406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of measuring non-HDL cholesterol in type 2 diabetes patients.
    Ram N; Ahmed B; Hashmi F; Jabbar A
    J Pak Med Assoc; 2014 Feb; 64(2):124-8. PubMed ID: 24640797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low levels of high-density lipoprotein cholesterol predict the presence of coronary artery disease in patients with aortic aneurysms.
    Saigusa T; Izawa A; Miura T; Ebisawa S; Shiba Y; Miyashita Y; Tomita T; Koyama J; Fukui D; Takano T; Amano J; Ikeda U
    Angiology; 2014 Sep; 65(8):710-5. PubMed ID: 24019083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
    Bonnet J; McPherson R; Tedgui A; Simoneau D; Nozza A; Martineau P; Davignon J;
    Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association of microalbuminuria and fasting insulin levels with presence and severity of coronary artery disease in non-diabetic cases].
    Ekicibaşi E; Kaderli AA; Kazazoğlu AR; Ozdemir B
    Anadolu Kardiyol Derg; 2008 Feb; 8(1):16-21. PubMed ID: 18258528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of serum HDL-C level in a Tehran urban population: the Tehran Lipid and Glucose Study.
    Azizi F; Raiszadeh F; Salehi P; Rahmani M; Emami H; Ghanbarian A; Hajipour R
    Nutr Metab Cardiovasc Dis; 2002 Apr; 12(2):80-9. PubMed ID: 12189907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved identification of patients with coronary artery disease by the use of new lipid and lipoprotein biomarkers.
    Johnston N; Jernberg T; Lagerqvist B; Siegbahn A; Wallentin L
    Am J Cardiol; 2006 Mar; 97(5):640-5. PubMed ID: 16490429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease.
    Xu RX; Zhang Y; Li XL; Li S; Guo YL; Dong Q; Liu G; Li JJ
    Clin Chim Acta; 2015 Jun; 446():195-200. PubMed ID: 25934512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of circulating cholesterol levels as a mediator of an association between ABO blood group and coronary heart disease.
    Chen Y; Chen C; Ke X; Xiong L; Shi Y; Li J; Tan X; Ye S
    Circ Cardiovasc Genet; 2014 Feb; 7(1):43-8. PubMed ID: 24395926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between lipid levels and major adverse cardiovascular events in rheumatoid arthritis compared to non-rheumatoid arthritis patients.
    Liao KP; Liu J; Lu B; Solomon DH; Kim SC
    Arthritis Rheumatol; 2015 May; 67(8):2004-10. PubMed ID: 25917955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of coronary calcium progression and control of lipids according to National Cholesterol Education Program guidelines.
    Wong ND; Kawakubo M; LaBree L; Azen SP; Xiang M; Detrano R
    Am J Cardiol; 2004 Aug; 94(4):431-6. PubMed ID: 15325924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group.
    Connelly PW; Petrasovits A; Stachenko S; MacLean DR; Little JA; Chockalingam A
    Can J Cardiol; 1999 Apr; 15(4):428-33. PubMed ID: 10322252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study.
    Colquhoun D; Keech A; Hunt D; Marschner I; Simes J; Glasziou P; White H; Barter P; Tonkin A;
    Eur Heart J; 2004 May; 25(9):771-7. PubMed ID: 15120888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.